Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia flag Australia · Delayed Price · Currency is AUD
2.980
-0.200 (-6.29%)
Aug 29, 2025, 4:10 PM AEST

Clarity Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Aug '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2018 - 2020
1,1088041,689182132-
Upgrade
Market Cap Growth
-52.42%-52.42%825.73%38.70%--
Upgrade
Enterprise Value
1,0246921,65110735-
Upgrade
Last Close Price
2.982.505.420.700.51-
Upgrade
PS Ratio
117.1384.93146.7918.6220.37-
Upgrade
PB Ratio
12.288.9111.552.641.43-
Upgrade
P/TBV Ratio
12.288.9111.552.641.43-
Upgrade
EV/Sales Ratio
108.2473.18143.4910.875.40-
Upgrade
Asset Turnover
0.070.070.100.110.110.20
Upgrade
Quick Ratio
9.089.0818.449.9513.199.91
Upgrade
Current Ratio
9.699.6919.0510.1713.2610.00
Upgrade
Return on Equity (ROE)
-54.37%-54.37%-39.28%-30.48%-42.23%-71.89%
Upgrade
Return on Assets (ROA)
-33.76%-33.76%-23.87%-18.65%-17.41%-40.63%
Upgrade
Return on Capital (ROIC)
-36.52%-36.52%-25.65%-20.42%-18.94%-45.34%
Upgrade
Earnings Yield
-5.80%-8.00%-2.51%-13.48%-18.06%-
Upgrade
FCF Yield
-4.96%-6.84%-2.59%-15.10%-10.28%-
Upgrade
Buyback Yield / Dilution
-16.86%-16.86%-5.22%-4.81%-40.37%-20.54%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.